Close

More on SGEN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (-18.8% Growth)
- Ratings (3.0 Score)
- Holders
- Event Driven Deals
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (2/8/24)
- M&A (3/31/18 *Est)
- M&A (12/31/23 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Seagen (NQ:SGEN)
Delayed: 218.33 --0 (-0%)
Prev. Close $218.33  
Open$218.33 
52 Wk High$75.36 
52 Wk Low$26.02 
Day High$218.33 
Day Low$218.33 
P/E N/A  
EPS$-0.51 
Volume26 

Friends, Peers and Foes (?): PFE, ALPMY, MRK, TSLA, UNP (more...)

Dec 6, 2023 08:16 AM Seagen (SGEN) Announces TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves PFS in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer
Dec 6, 2023 08:15 AM TUKYSA® (tucatinib) in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Free Survival in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer
Nov 30, 2023 05:00 PM Seagen (SGEN) Announces FDA Grants Priority Review for sBLA of PADCEV with KEYTRUDA for First-Line Treatment of Advanced Bladder Cancer
Nov 30, 2023 05:00 PM FDA Grants Priority Review for Supplemental Biologics License Application (sBLA) of PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Advanced Bladder Canc
Nov 13, 2023 09:38 PM Form 144/A Seagen Inc. Filed by: Epstein David R
Nov 13, 2023 08:02 PM Form 4 Seagen Inc. For: Nov 10 Filed by: Epstein David R
Nov 13, 2023 07:33 PM Form 4 Seagen Inc. For: Nov 09 Filed by: HIMES VAUGHN B
Nov 13, 2023 06:38 PM Form 144 Seagen Inc. Filed by: Epstein David R
Nov 9, 2023 04:14 PM Form 144 Seagen Inc. Filed by: HIMES VAUGHN B
Nov 3, 2023 12:00 PM Seagen Highlights First Solid Tumor Data for an ADCETRIS® (brentuximab vedotin) Immunotherapy Combination and Preclinical Data for Novel CD30-Directed Antibody-Drug Conjugate at Society for Immunothe
View All Articles

Entities mentioned with SGEN

View All Entities